Search

Author/Creator Katz, Artur

1. Alectinib activity in chemotherapy-refractory metastatic RET-rearranged non-small cell lung carcinomas: A case series. (January 2020)

Authors:
Ribeiro, Maurício Fernando Silva Almeida; Alessi, João Victor Machado; Oliveira, Leandro Jonata Carvalho; Gongora, Aline Bobato Lara; Sacardo, Karina Perez; Zucchetti, Bruna Migliavacca; Shimada, Andrea Kazumi; de Galiza Barbosa, Felipe; Feher, Olavo; Katz, Artur
Journal:
Lung cancer
Issue:
Volume 139(2020)
Page Start:
9
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Cost-effectiveness analysis of Oncotype DX from a Brazilian private medicine perspective: a GBECAM multicenter retrospective study. (December 2022)

Authors:
Oliveira, Leandro Jonata Carvalho; Megid, Thais Baccili Cury; Rosa, Daniela Dornelles; Magliano, Carlos Alberto da Silva; Assad, Daniele Xavier; Argolo, Daniel Fontes; Sanches, Solange Moraes; Testa, Laura; Bines, José; Kaliks, Rafael; Caleffi, Maira; de Melo Gagliato, Debora; Sahade, Marina; Bar...
Journal:
Therapeutic advances in medical oncology
Issue:
Volume 14(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Identification of the TP53 p.R337H Variant in Tumor Genomic Profiling Should Prompt Consideration of Germline Testing for Li-Fraumeni Syndrome. (2021)

Authors:
Sandoval, Renata Lazari; Masotti, Cibele; de Macedo, Mariana Petaccia; Ribeiro, Maurício Fernando Silva Almeida; Leite, Ana Carolina Rathsam; Meireles, Sibele Inacio; Bovolin, Rodrigo Medeiros; Santini, Fernando Costa; Munhoz, Rodrigo Ramella; Jardim, Denis Leonardo Fontes; Katz, Artur; Camargo, ...
Journal:
JCO global oncology
Issue:
Volume 7(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Selecting postoperative adjuvant systemic therapy for early stage breast cancer: A critical assessment of commercially available gene expression assays. Issue 6 (17th February 2017)

Authors:
Hyams, David M.; Schuur, Eric; Angel Aristizabal, Javier; Bargallo Rocha, Juan Enrique; Cabello, Cesar; Elizalde, Roberto; García‐Estévez, Laura; Gomez, Henry L.; Katz, Artur; Nuñez De Pierro, Aníbal
Journal:
Journal of surgical oncology
Issue:
Volume 115:Issue 6(2017)
Page Start:
647
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Sequential liquid biopsies reveal dynamic alterations of EGFR driver mutations and indicate EGFR amplification as a new mechanism of resistance to osimertinib in NSCLC. (June 2017)

Authors:
Knebel, Franciele H.; Bettoni, Fabiana; Shimada, Andrea K.; Cruz, Manoel; Alessi, João Victor; Negrão, Marcelo V.; Reis, Luiz Fernando L.; Katz, Artur; Camargo, Anamaria A.
Journal:
Lung cancer
Issue:
Volume 108(2017)
Page Start:
238
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Unique SLC12A2-ROS1 fusion is associated with marked response to crizotinib in lung adenocarcinoma. (May 2022)

Authors:
Ribeiro, Maurício Fernando Silva Almeida; Gadotti, Luiza Lara; Sacardo, Karina Perez; Lopes, Carlos Diego Holanda; Saddi, Rodrigo; Alessi, João Victor Machado; de Macedo, Mariana Petaccia; do Nascimento, Ellen Caroline Toledo; Testagrossa, Leonardo de Abreu; Katz, Artur
Journal:
SAGE open medical case reports
Issue:
Volume 10(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗